Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Digitalis Ventures is a venture capital firm founded in New York City, dedicated to addressing unmet needs in health. The firm focuses on providing venture capital to early-stage companies in life sciences, health technologies, and animal health. Digitalis Ventures is part of the Digitalis Group, which includes Digitalis Research and Digitalis Commons, enhancing its capabilities and reach.
The firm operates from its office located at 11 Times Square, Suite 1500A, New York, NY 10036. Digitalis Ventures emphasizes a multidisciplinary approach, leveraging a diverse team and an expansive network of entrepreneurs, technical experts, research institutions, and financial partners to support its portfolio companies throughout their development.
While specific metrics such as assets under management (AUM) and fund size are not disclosed, the firm is recognized for its commitment to investing in innovative solutions that improve health outcomes. Digitalis Ventures has established itself as a key player in the early-stage investment landscape, particularly in the biotech and health technology sectors.
Digitalis Ventures invests primarily in biotechnology companies that utilize breakthrough science to enhance human health. The firm also targets technology-enabled solutions that aim to improve access to care and health outcomes while reducing costs. This investment strategy encompasses a wide range of sectors, including life sciences, health technologies, and animal health.
In addition to its core focus on human health, Digitalis Ventures operates Companion Funds that specifically support innovations in animal health. These funds partner with organizations like Mars Petcare to invest in companies that leverage science, technology, and design to improve animal health. The firm typically invests at the pre-seed, seed, seed-plus, and Series A stages, primarily within North America.
Digitalis Ventures seeks founders who are passionate about solving significant health challenges and who possess a strong vision for their companies. The firm values innovative approaches and is interested in deal structures that allow for collaborative growth and shared success.
Digitalis Ventures has a diverse portfolio that includes companies focused on both human and animal health. In the human health sector, notable investments include:
In the animal health sector, Digitalis Ventures has invested in:
Geoffrey W. Smith: Founder / Managing Partner. Geoffrey has extensive experience in venture capital and has led numerous successful investments in the health sector.
Misti Ushio: Managing Partner. Misti brings a wealth of knowledge in health technologies and has a strong background in supporting early-stage companies.
Samuel Bjork: Partner. Samuel specializes in biotechnology investments and has a track record of identifying promising startups in the life sciences.
Amit Bansal: Partner. Amit has a background in both finance and healthcare, providing a unique perspective on investment opportunities.
Ben Jacobs: Partner. Ben focuses on technology-enabled health solutions and has experience in scaling health tech companies.
Drew Taylor: Venture Partner. Drew has a strong network in the health sector and supports portfolio companies with strategic guidance.
Dac Nguyen: Technical Partner. Dac provides technical expertise to portfolio companies, helping them navigate product development challenges.
Cindy Cole: Technical Partner. Cindy specializes in health technologies and assists companies in refining their product offerings.
Travis Hughes: Principal. Travis focuses on sourcing new investment opportunities and supporting portfolio companies.
Lauren Holtvoigt: Associate. Lauren assists in due diligence and supports the investment team.
Michael Fall: Associate. Michael works on portfolio management and helps with operational support for portfolio companies.
Bo Stewart: Associate. Bo focuses on market research and analysis to identify trends in health innovation.
Haiming Chen: Senior Accounting Manager. Haiming oversees financial operations within the firm.
Dylan Henderson: Accounting Manager. Dylan supports the accounting team and ensures financial accuracy.
Steve Allen: Emeritus Partner. Steve has a long history in venture capital and continues to provide insights to the firm.
To pitch Digitalis Ventures, founders should submit their proposals through the firm's website at digitalisventures.com. The pitch deck should include a clear overview of the business model, market opportunity, and team qualifications. Founders are encouraged to provide data supporting their claims and outline their vision for growth.
Response times may vary, but founders can expect to hear back within a few weeks. Warm introductions are preferred, as they can facilitate a more favorable review process.
Digitalis Ventures collaborates with Michelsen Found Animals and R/GA Ventures to operate the Leap Venture Studio. This accelerator program focuses on early-stage companies in the animal health sector, providing resources, mentorship, and networking opportunities to help startups grow and succeed.
Eligibility for the Leap Venture Studio typically includes being an early-stage company with a focus on innovative solutions in animal health. Interested founders can apply through the program's website for consideration.
In recent months, Digitalis Ventures has continued to expand its portfolio, focusing on innovative companies in the health sector. The firm has made several investments in biotechnology and technology-enabled health solutions, aligning with its mission to enhance human health.
Digitalis Ventures has also been active in supporting its portfolio companies through mentorship and operational guidance, ensuring they have the resources needed to succeed in a competitive market.
Additionally, the firm has collaborated with Michelsen Found Animals and R/GA Ventures to run the Leap Venture Studio, an accelerator program aimed at early-stage companies in animal health.
What are Digitalis Ventures' investment criteria?
Digitalis Ventures invests in early-stage companies focused on biotechnology and technology-enabled health solutions. The firm looks for innovative approaches that address significant health challenges, particularly in life sciences and animal health.
How can founders apply or pitch to Digitalis Ventures?
Founders can pitch their ideas through the firm's website at digitalisventures.com. It is advisable to include a clear business plan, market analysis, and details about the team in the pitch deck.
What makes Digitalis Ventures different from other venture capital firms?
Digitalis Ventures distinguishes itself through its focus on both human and animal health, leveraging a multidisciplinary team and an expansive network to support portfolio companies. The firm also operates Companion Funds dedicated to animal health innovations.
What is the geographic scope of Digitalis Ventures' investments?
The firm primarily invests in North America, focusing on early-stage companies that are addressing unmet health needs.
What is the typical check size for investments made by Digitalis Ventures?
While specific check sizes are not disclosed, Digitalis Ventures focuses on pre-seed, seed, seed-plus, and Series A stages, indicating a range that typically aligns with early-stage funding.
What kind of post-investment involvement does Digitalis Ventures have?
Digitalis Ventures actively supports its portfolio companies through mentorship, access to a network of experts, and resources that facilitate growth and development.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.